Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Troxerutin in Preventing Thrombotic Events in COVID-19 Patients
NCT06355258Phase 1Recruiting
- Sponsor
- Westlake University
- Start
- Dec 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of troxerutin in coronavirus disease 2019 (COVID-19) (4 arms), sponsored by Westlake University. Primary endpoint: Overall number of patients in prothrombotic state at 7 days. Started Dec 2023; status: recruiting.
02
Drugs
troxerutin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT06355258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06355258.